Autolus Therapeutics plc (AUTL) Total liabilities 2017–2025
Autolus Therapeutics plc (AUTL) total liabilities at each fiscal year-end, per SEC filings.
$410.9MFY2025 · since FY2017: $6.1M → $410.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $410.9M | +15.6% |
| FY2024 | $355.4M | +34.7% |
| FY2023 | $263.9M | — |
| FY2019 | $48.7M | +174.5% |
| FY2018 | $17.7M | +192.7% |
| FY2017 | $6.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More AUTL financial trends
AUTL RevenueAUTL Net incomeAUTL Net marginAUTL Gross profitAUTL Gross marginAUTL Operating incomeAUTL Operating marginAUTL Operating cash flowAUTL Free cash flowAUTL Capital expendituresAUTL Return on equityAUTL Stock buybacksAUTL Dividends paidAUTL Total assetsAUTL Shareholders’ equityAUTL overview →